First-of-its-kind cell therapy approved by FDA for rare soft tissue cancer | BioPharma Dive

Retrieved on: 2024-08-02 21:01:40

Tags for this article:

Click the tags to see associated articles and topics

First-of-its-kind cell therapy approved by FDA for rare soft tissue cancer | BioPharma Dive. View article details on hiswai:

Excerpt

Adaptimmune's Tecelra is the first TCR cell therapy to reach the U.S. market, but arrives with only modest sales expectations. Published Aug.

Article found on: www.biopharmadive.com